Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
50%
Ph phase_3
1
25%
Ph phase_2
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)

Trials by Status

withdrawn125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

NCT04082975
completedphase_2

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

NCT03341832
withdrawnphase_1

Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

NCT02289274
completedphase_1

A Study to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203

NCT02289404

Clinical Trials (4)

Showing 4 of 4 trials
NCT04082975Phase 3

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

Completed
NCT03341832Phase 2

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

Completed
NCT02289274Phase 1

Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

Withdrawn
NCT02289404Phase 1

A Study to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4